RA - Latest News
Brookfield Real Assets Income (RA), operates in Financial Services / Asset Management, trades on NYSE.
Market capitalization stands near $639.3M.
The article list below shows the most recent RA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RA Headlines
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
gurufocus.com - Oct 11, 2026
New SKYRIZIÂ (risankizumab-rzaa) and RINVOQÂ (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel DiseasePR New
Brookfield Real Assets Income Fund Inc. (NYSE:RA) Shareholders Set to Receive $0.12 Monthly Dividend
defenseworld.net - Oct 7, 2026
Brookfield Real Assets Income Fund Inc. (NYSE: RA - Get Free Report) declared a monthly dividend on Friday, September 25th.
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
gurufocus.com - Sep 30, 2026
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congre
Brookfield Real Assets Income Fund (NYSE:RA) Stock Sale Disclosed by Rep. Kevin Hern
defenseworld.net - Sep 29, 2026
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Brookfield Real Assets Income Fund Inc. (NYSE: RA).
Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule
globenewswire.com - Sep 25, 2026
NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc.
Frequently asked RA news questions
- What is the latest RA news headline?
- The most recent RA headline (Oct 11, 2026) is "New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.